Hi James,
I think you're correct that Ronen could be selling to raise cash to invest in a new venture, as did Eyton when Emefcy evolved into Fluence. I seem to remember that both of them were also adversely affected by onerous Israeli tax regulations regarding their Australian holdings.
Ronen obviously has no qualms about creating a disorderly market with his big dumps. There's actually an ASX rule about that, but it's up to individual brokers to enforce it. I've had orders knocked back by Commsec based on that rule, but then I'm only a little fish in a big pond.
- Forums
- ASX - By Stock
- FLC
- Chart
Chart, page-468
-
- There are more pages in this discussion • 606 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FLC (ASX) to my watchlist
|
|||||
Last
13.0¢ |
Change
0.010(8.33%) |
Mkt cap ! $140.5M |
Open | High | Low | Value | Volume |
12.5¢ | 13.0¢ | 12.0¢ | $7.328K | 60.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 145000 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 126036 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 145000 | 0.120 |
2 | 150663 | 0.115 |
5 | 216167 | 0.110 |
1 | 50000 | 0.105 |
1 | 200000 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 126036 | 4 |
0.135 | 50000 | 1 |
0.140 | 56092 | 3 |
0.145 | 120000 | 3 |
0.150 | 146000 | 4 |
Last trade - 13.21pm 15/07/2024 (20 minute delay) ? |
Featured News
FLC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online